Intelligent Personal Assistants for Delivering Telehealth to Postmenopausal Women with Osteoporosis

Not Applicable

• Conditions: osteoporosis; postmenopausal osteoporosis; Musculoskeletal - Osteoporosis; Reproductive Health and Childbirth - Menstruation and menopause

• Registration Number: ACTRN12621000147886
• Lead Sponsor: Deakin University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-02-12
• Last Update Posted: 22 February 2021

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: Female
• Target Recruitment: 50

Inclusion Criteria

English-speaking, women aged 50 years and older who have experienced menopause, self-reported diagnosis of osteoporosis and is currently receiving an approved drug treatment on a monthly, six-monthly or annual schedule, safely able to complete an unsupervised home-based exercise program, has a Medicare number and is willing to consent to data linkage, and has access to a personal email address via home computer/tablet/smartphone and a home Wi-Fi network.

Exclusion Criteria

Participants are ineligible if they report currently being unable to walk across a room unaided; are non-English speaking or have difficulty communicating with study personnel or a VIPA device due to speech or hearing problems; unwilling to be randomised; planning to be away from the VIPA device for greater than or equal to 4 weeks during the 6-month intervention period; severe knee or hip osteoarthritis (awaiting a joint replacement) that would interfere with ability to complete exercise; recent fracture (past 3 months) limiting exercise; renal disease requiring dialysis; and any other disorder of such severity that life expectancy is less than 12 months, or any cognitive or physical impairment or disability that in the opinion of the study investigators would result in the participant having difficulty interacting with Buddy Link or performing unsupervised exercise safely. Participants who answer ‘yes’ to any of six questions on the Exercise and Sports Science Australia (ESSA) pre-exercise screening tool will also be excluded. This is a validated and recommended pre-exercise screening tool for ensuring safety for exercise at moderate exertion, endorsed by Australia’s peak exercise body (ESSA).

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Medication adherence assessed using the Medication Possession Ratio (MPR; the percentage of time the participant has access to a prescribed osteoporosis medication)[Baseline<br>12 months post-intervention commencement]